Skip to content
6-K

Foreign Interim / Material

MEDICURE INC MCUJF

0001654954-25-006007

← back to feed
Filed
May 21, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2025 · Mar 31, 2025 10.44M sh
Shares Diluted Q1 2025 · Mar 31, 2024 10.44M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 656K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −132K
Cash And Equivalents Q1 2025 · Mar 31, 2025 7.22M
Cash And Equivalents Q1 2025 · Dec 31, 2024 7.19M
Stockholders Equity Q1 2025 · Mar 31, 2025 20.1M
Stockholders Equity Q1 2025 · Dec 31, 2024 20.78M
Stockholders Equity Q1 2025 · Mar 31, 2024 20.5M
Stockholders Equity Q1 2025 · Dec 31, 2023 19.9M
Current Liabilities Q1 2025 · Mar 31, 2025 9.24M
Current Liabilities Q1 2025 · Dec 31, 2024 8.4M
Total Liabilities Q1 2025 · Mar 31, 2025 9.68M
Total Liabilities Q1 2025 · Dec 31, 2024 8.9M
Current Assets Q1 2025 · Mar 31, 2025 15.78M
Current Assets Q1 2025 · Dec 31, 2024 15.9M
Total Assets Q1 2025 · Mar 31, 2025 29.78M
Total Assets Q1 2025 · Dec 31, 2024 29.68M
Eps Diluted Q1 2025 · Mar 31, 2025 −0.07
Eps Diluted Q1 2025 · Mar 31, 2024 0.00
Eps Basic Q1 2025 · Mar 31, 2025 −0.07
Eps Basic Q1 2025 · Mar 31, 2024 0.00
Rd Expense Q1 2025 · Mar 31, 2025 570K
Rd Expense Q1 2025 · Mar 31, 2024 676K
Net Income Q1 2025 · Mar 31, 2025 −694K
Net Income Q1 2025 · Mar 31, 2024 51K
Gross Profit Q1 2025 · Mar 31, 2025 2.84M
Gross Profit Q1 2025 · Mar 31, 2024 3.9M
Cost Of Revenue Q1 2025 · Mar 31, 2025 2.64M
Cost Of Revenue Q1 2025 · Mar 31, 2024 1.8M
Revenue Q1 2025 · Mar 31, 2025 5.48M
Revenue Q1 2025 · Mar 31, 2024 5.69M